IT1261863B - Oral pharmaceutical preparations based on controlled delayed release of diltiazem, with which it is possible to use only one daily administration - Google Patents
Oral pharmaceutical preparations based on controlled delayed release of diltiazem, with which it is possible to use only one daily administrationInfo
- Publication number
- IT1261863B IT1261863B ITRM930732A ITRM930732A IT1261863B IT 1261863 B IT1261863 B IT 1261863B IT RM930732 A ITRM930732 A IT RM930732A IT RM930732 A ITRM930732 A IT RM930732A IT 1261863 B IT1261863 B IT 1261863B
- Authority
- IT
- Italy
- Prior art keywords
- diltiazem
- pharmaceutical preparations
- delayed release
- oral pharmaceutical
- daily administration
- Prior art date
Links
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 title abstract 2
- 229960004166 diltiazem Drugs 0.000 title abstract 2
- 230000003111 delayed effect Effects 0.000 title 1
- 239000008183 oral pharmaceutical preparation Substances 0.000 title 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Abstract
Pharmaceutical preparations for oral use based on diltiazem characterised in that they yield up the active substance in a controlled way over an extended period (approximately 14 hours) are described. These preparations find application in the treatment and prophylaxis of heart failure and make it possible to use a particularly advantageous dosage (one administration per day).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM930732A IT1261863B (en) | 1993-11-05 | 1993-11-05 | Oral pharmaceutical preparations based on controlled delayed release of diltiazem, with which it is possible to use only one daily administration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM930732A IT1261863B (en) | 1993-11-05 | 1993-11-05 | Oral pharmaceutical preparations based on controlled delayed release of diltiazem, with which it is possible to use only one daily administration |
Publications (3)
Publication Number | Publication Date |
---|---|
ITRM930732A0 ITRM930732A0 (en) | 1993-11-05 |
ITRM930732A1 ITRM930732A1 (en) | 1995-05-05 |
IT1261863B true IT1261863B (en) | 1996-06-03 |
Family
ID=11402039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITRM930732A IT1261863B (en) | 1993-11-05 | 1993-11-05 | Oral pharmaceutical preparations based on controlled delayed release of diltiazem, with which it is possible to use only one daily administration |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1261863B (en) |
-
1993
- 1993-11-05 IT ITRM930732A patent/IT1261863B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ITRM930732A0 (en) | 1993-11-05 |
ITRM930732A1 (en) | 1995-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2040232T3 (en) | MEDICINAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING A SINGLE DOSE OF 10 TO 240 MG OF DIHIDROPIRIDINA. | |
MY131796A (en) | Use of glp-1 or analogs in treatment of myocardial infraction | |
WO2000016797A3 (en) | Use of glp-1 or analogs in treatment of stroke | |
AU2506388A (en) | Azelastine-containing medicaments for application in the nose and/or at the eye | |
AU2584192A (en) | Bone-growth-stimulating composition | |
CA2149329A1 (en) | Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma | |
IL91276A0 (en) | Pharmaceutical compositions containing alpha-amino boronic acid derivatives,for the prophylaxis and treatment of virus diseases | |
SE8804629A (en) | ||
GR3031044T3 (en) | Pharmaceutical and/or cosmetic preparation and the use of the preparation | |
TW362973B (en) | Use of 2-anino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a composition having an antidepressant activity | |
NZ229518A (en) | Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment | |
AU1277792A (en) | Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts | |
PH27446A (en) | Compound with gastric acid inhibitory effect | |
EP0302714A3 (en) | Pharmaceutical composition for treatment of bone-wasting diseases | |
EP1304108A3 (en) | Anti-arrhythmic composition and methods of treatment | |
EP0429522A4 (en) | Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs | |
AU3401093A (en) | Therapeutic agent for threatened abortion | |
IT1261863B (en) | Oral pharmaceutical preparations based on controlled delayed release of diltiazem, with which it is possible to use only one daily administration | |
ATE247462T1 (en) | USE OF METFORMIN FOR WEIGHT GAIN ASSOCIATED WITH VALPROATE AND OTHER PSYCHOTROPIC DRUGS | |
AU7076494A (en) | Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease | |
CO5031290A1 (en) | FORMULATION LO | |
IL110888A0 (en) | Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative | |
IT1264080B1 (en) | Oral delayed- and controlled-release pharmaceutical preparations based on isorbide nitrates with which it is possible to use only one daily administration | |
AU3429393A (en) | Pharmaceutical pentapeptide compositions and methods of use thereof | |
UA19497A (en) | Method for treatment of chronic toxic hepatitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19961122 |